These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 1356426
1. Platelet monoamine oxidase in schizophrenia: a meta-analysis. Marcolin MA, Davis JM. Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426 [Abstract] [Full Text] [Related]
2. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs. Kemali D, Maj M, Ariano MG, Salvati A. Encephale; 1985 Sep; 11(1):31-4. PubMed ID: 2859981 [Abstract] [Full Text] [Related]
3. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients. Meltzer HY, Duncavage MB, Jackman H, Arora RC, Tricou BJ, Young M. Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035 [Abstract] [Full Text] [Related]
4. Human platelet MAO in drug-free and medicated schizophrenic patients. Friedhoff AJ, Miller JC, Weisenfreund J. Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104 [Abstract] [Full Text] [Related]
6. Effects of neuroleptics on platelet monoamine oxidase activity. Ho BT, Smith RC, Kralik P, Allen R, Schoolar J, Khan M, DeJohn C. Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230 [Abstract] [Full Text] [Related]
7. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity. Bridge TP, Jeste DV, Wise CD, Potkin SG, Phelps BH, Wyatt RJ. Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337 [Abstract] [Full Text] [Related]
8. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia. Baron M, Gruen R, Levitt M, Kane J. Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754 [Abstract] [Full Text] [Related]
9. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment? Del Vecchio M, Maj M, D'Ambrosio A, Kemali D. Psychopharmacology (Berl); 1983 Oct; 79(2-3):177-9. PubMed ID: 6133302 [Abstract] [Full Text] [Related]
10. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome. Mann J, Thomas KM. Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192 [Abstract] [Full Text] [Related]
11. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients. DeLisi LE, Wise CD, Bridge TP, Rosenblatt JE, Wagner RL, Morihisa J, Karson C, Potkin SG, Wyatt RJ. Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821 [Abstract] [Full Text] [Related]
12. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines. Takahashi S, Yamane H, Tani N. Folia Psychiatr Neurol Jpn; 1975 Feb; 29(3):207-14. PubMed ID: 2524 [Abstract] [Full Text] [Related]
13. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations. Rose RM, Castellani S, Boeringa JA, Malek-Ahmadi P, Lankford DA, Bessman JD, Fritz RR, Denney CB, Denney RM, Abell CW. Psychiatry Res; 1986 Feb; 17(2):141-51. PubMed ID: 2870529 [Abstract] [Full Text] [Related]
14. Platelet monoamine oxidase activity in schizophrenic patients. Becker RE, Shaskan EG. Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577 [Abstract] [Full Text] [Related]
15. Platelet MAO in schizophrenics: relationship to symptomatology and neuroleptics. Paik IH, Lee C, Kim CE. Biol Psychiatry; 1988 Jan 01; 23(1):93-5. PubMed ID: 2892539 [No Abstract] [Full Text] [Related]